US Stock Futures Signal Lower Start On Wall Street - BioLife Solns (NASDAQ:BLFS), Atara Biotherapeutics (NASDAQ:ATRA)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Pre-open moversUS stock futures traded lower in early pre-market trade. The Chicago PMI for August will be released at 9:45 a.m. ET, while the Dallas Fed manufacturing index for August will be released at 10:30 a.m. ET. Data on farm prices for August will be released at 3:00 p.m. ET. Futures for the Dow Jones Industrial Average dipped 127.5 points to 16,531.5, while the Standard & Poor's 500 index futures fell 15.25 points to 1,974.50. Futures for the Nasdaq 100 index dropped 29 points to 4,304.00.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

A Peek Into Global MarketsEuropean markets were lower today, with the Spanish Ibex Index falling 0.57 percent, STOXX Europe 600 Index falling 0.04 percent and German DAX 30 index dropping 0.49 percent. French CAC 40 Index slipped 0.60 percent.In Asian markets, Japan's Nikkei Stock Average fell 1.28 percent, Hong Kong's Hang Seng Index rose 0.27 percent, China's Shanghai Composite Index dropped 0.82 percent and India's BSE Sensex declined 0.41 percent.Broker RecommendationAnalysts at SunTrust Robinson Humphrey upgraded

Twitter Inc (NYSE: TWTR) from Neutral to Buy and maintained the price target of $38.00.Twitter shares gained 2.01 percent to $27.37 in pre-market trading.Breaking news

BioLife Solutions Inc (NASDAQ: BLFS) today announced that its customer TiGenix NV, recently disclosed that its lead compound Cx601 met the primary endpoint in the Phase III ADMIRE-CD trial of complex perianal fistula in Crohn's Disease patients. To read the full news, click here.
Atara Biotherapeutics Inc (NASDAQ: ATRA) today announced that it completed enrollment in its blinded, randomized, PINTA 745 Phase 2 clinical trial in End-Stage Renal Disease patients with Protein Energy Wasting. To read the full news, click here.
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc (NYSE: DVA) and a leading global provider of kidney care services, today announced it is forming a joint venture kidney care specialty hospital chain in Shandong province China. To read the full news, click here.
Disguise, Inc., the Halloween costume division of leading toy manufacturer, JAKKS Pacific, Inc. (NASDAQ: JAKK), announced today that it has secured a licensing agreement with the LEGO Group to "construct" children's Halloween costumes, role play and accessories based on popular LEGO® characters. To read the full news, click here.